| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.002 |